Vice Health and Wellness Inc. (CNSX:VICE) signed non-binding Letter of Intent to acquire Naltrexone Therapeutics Inc. on July 24, 2023. The total consideration for the transaction is 10 million common shares of Vice at a deemed value of CAD 0.05 per share. The Company anticipates closing the transaction within 30 days, subject to final due diligence.

Vice Health and Wellness Inc. (CNSX:VICE) canceled the acquisition of Naltrexone Therapeutics Inc. on August 1, 2023.